- Home
- GDRX vs BCRX Comparison
GDRX vs BCRX Comparison
Compare GDRX & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDRX
- BCRX
- Stock Information
- Founded
- GDRX 2011
- BCRX 1986
- Country
- GDRX United States
- BCRX United States
- Employees
- GDRX N/A
- BCRX N/A
- Industry
- GDRX Retail: Computer Software & Peripheral Equipment
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDRX Technology
- BCRX Health Care
- Exchange
- GDRX Nasdaq
- BCRX Nasdaq
- Market Cap
- GDRX N/A
- BCRX 1.7B
- IPO Year
- GDRX 2020
- BCRX 1994
- Fundamental
- Price
- GDRX $4.57
- BCRX $7.27
- Analyst Decision
- GDRX Buy
- BCRX Buy
- Analyst Count
- GDRX 10
- BCRX 6
- Target Price
- GDRX $8.68
- BCRX $15.67
- AVG Volume (30 Days)
- GDRX 1.6M
- BCRX 3.1M
- Earning Date
- GDRX 05-08-2025
- BCRX 05-05-2025
- Dividend Yield
- GDRX N/A
- BCRX N/A
- EPS Growth
- GDRX N/A
- BCRX N/A
- EPS
- GDRX 0.04
- BCRX N/A
- Revenue
- GDRX $792,324,000.00
- BCRX $450,712,000.00
- Revenue This Year
- GDRX $6.14
- BCRX $27.66
- Revenue Next Year
- GDRX $6.58
- BCRX $13.59
- P/E Ratio
- GDRX $115.13
- BCRX N/A
- Revenue Growth
- GDRX 5.61
- BCRX 36.00
- 52 Week Low
- GDRX $4.09
- BCRX $4.03
- 52 Week High
- GDRX $9.26
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- GDRX 48.08
- BCRX 39.99
- Support Level
- GDRX $4.32
- BCRX $7.44
- Resistance Level
- GDRX $4.75
- BCRX $7.93
- Average True Range (ATR)
- GDRX 0.22
- BCRX 0.25
- MACD
- GDRX -0.00
- BCRX -0.03
- Stochastic Oscillator
- GDRX 40.94
- BCRX 28.86
Stock Price Comparison Chart: GDRX vs BCRX
■ GDRX
■ BCRX
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Share on Social Networks:
0